Best Ketamine Therapy Options for Veterans (2026)

Veterans face disproportionately high rates of PTSD, treatment-resistant depression, and chronic pain — and disproportionately high barriers to accessing effective treatment. Ketamine has emerged as one of the most evidence-backed options for veterans with treatment-resistant PTSD and depression, in part because of a 2021 randomized controlled trial that used veterans as the primary study population. This guide covers the organizations and programs with the most transparent, evidence-aligned approaches to ketamine therapy for veterans.

Evidence for ketamine in veteran PTSD and depression

The landmark 2021 trial by Feder et al. (published in the American Journal of Psychiatry) enrolled veterans and active-duty service members with chronic PTSD and administered six intravenous ketamine infusions over three weeks. The result: a statistically and clinically significant reduction in PTSD symptoms on the CAPS-5 scale compared to midazolam (an active control). This is the strongest RCT evidence base for ketamine in PTSD to date.

A separate line of research has established ketamine's efficacy in treatment-resistant depression — relevant because the majority of veterans with PTSD also carry a comorbid major depressive episode. Ketamine's rapid onset (hours to days vs. weeks for SSRIs) is especially significant for veterans in acute distress.

A separate 2024 Stanford trial published in Nature Medicine (the MISTIC study) used ibogaine — not ketamine — with veterans with TBI. We mention it here because it is frequently confused with the ketamine PTSD literature. See our ibogaine guide for that research.

1. VETS (Veterans Exploring Treatment Solutions) — Grant-Funded Treatment

VETS (Veterans Exploring Treatment Solutions) is a nonprofit that funds psychedelic and ketamine therapy for post-9/11 veterans. Rather than providing treatment directly, VETS connects veterans with vetted clinical providers and grants that can cover treatment costs — including ketamine infusion, MDMA-assisted therapy (for those in trials), and psilocybin-assisted programs.

VETS has funded over 1,000 veteran treatments as of 2024 and has published preliminary outcome data on their veteran cohort. The application process requires a service record and documentation of the condition being treated. Processing times vary.

• Strengths: Direct financial assistance for eligible post-9/11 veterans; covers multiple modalities (ketamine, MDMA, psilocybin); outcome data published.
• Limitations: Application and vetting process required; funding is grant-based and subject to availability; not all veterans are eligible (post-9/11 service requirement).
• Cost to veteran: Potentially $0 for eligible veterans (grant-funded). Apply at vets.org (verify URL before applying).

2. VA Spravato Coverage — Easiest Insurance Path

Spravato (esketamine nasal spray) is the only FDA-approved esketamine product for treatment-resistant depression. The VA covers Spravato for eligible veterans at VA facilities under certain conditions. This is the clearest insurance-covered path to ketamine-class treatment for veterans with access to VA health care.

Spravato requires in-office administration (you cannot take it at home — this is a legal requirement). Sessions are typically 2 hours at the VA facility, administered twice weekly for the first month and then weekly or biweekly. The VA's coverage policies for Spravato vary by facility and region — verify with your local VA.

• Strengths: Potentially no out-of-pocket cost for VA-enrolled veterans; FDA-approved; supervised administration reduces safety risk.
• Limitations: In-office administration required (2 hours per visit); not all VA facilities offer Spravato; indication is treatment-resistant depression, not directly PTSD.
• Cost to veteran: Covered by VA health care for eligible veterans with treatment-resistant depression. Copay may apply based on priority group.

3. Stella Center — PTSD, Depression, and TBI

Stella Center specializes in treating PTSD with two distinct approaches: ketamine infusions and the stellate ganglion block (SGB), a nerve block procedure in the neck that has shown early evidence for PTSD symptom reduction. Many veterans present with both PTSD and chronic pain — the SGB can address components of both.

Stella Center has multiple locations across the US (verify location availability). Their intake process screens for psychiatric history and contraindications before treatment. They have worked with veteran populations specifically and have published results in partnership with military health organizations.

• Strengths: Combined SGB + ketamine option; multiple US locations; veteran-focused clinical experience; published outcome data.
• Limitations: Cost is out-of-pocket for most veterans (SGB is sometimes covered, ketamine typically is not); not available in all areas.
• Typical cost: Ketamine infusion series: approximately $2,500–$5,000 out-of-pocket. SGB cost varies. Contact for current pricing and insurance verification.

4. Mindbloom — Veteran Discount Program

Mindbloom offers a documented veteran discount on their at-home ketamine program. Their program delivers compounded sublingual ketamine with app-guided session support. The clinical team includes nurse practitioners who conduct a telehealth evaluation before prescribing.

At-home ketamine is more accessible than IV infusion centers — no travel required, lower cost — but involves lower bioavailability and a self-directed environment. Veterans with complex PTSD presentations may do better in a supervised clinical setting.

• Strengths: Veteran discount documented; accessible (no travel required); established at-home platform.
• Limitations: At-home setting is self-directed; less appropriate for complex PTSD vs. a supervised clinical environment; no therapist included in base price.
• Typical cost: Approximately $168–$268/month after veteran discount. Verify current rates and discount eligibility with the provider.

5. Revitalist — Multi-Location Ketamine Clinics with Veteran Pricing

Revitalist is a ketamine clinic chain with locations in several US states, primarily in the South and Midwest. They have a documented veteran pricing program that reduces the cost of IV ketamine infusions for active military, veterans, and first responders.

Revitalist's clinical model includes a medical evaluation before the first infusion, a series of six infusions over approximately two weeks (standard protocol), and follow-up monitoring. Integration therapy is not included in the base package but can be added with a referral.

• Strengths: Documented veteran discount; IV ketamine (higher bioavailability than at-home); clinical supervision during infusions.
• Limitations: Geographic limitations; no integration therapy included; cost remains significant even with discount.
• Typical cost: Approximately $2,000–$3,500 for a six-infusion series after veteran discount. Contact for current pricing and location availability.

6. Warrior Angels Foundation

Warrior Angels Foundation is a nonprofit that supports veterans exploring psychedelic-assisted therapies, including ketamine, psilocybin, and MDMA. Rather than providing treatment directly, they offer case management and navigation support — helping veterans identify which trials they qualify for, which grants they can apply for, and which providers are most appropriate for their specific situation.

This "navigator" role is undervalued in a market where veterans may encounter both legitimate providers and inadequately screened programs. Warrior Angels' staff include veterans themselves.

• Strengths: Navigation support for complex veteran cases; covers multiple modalities; veteran-staffed; no treatment cost (navigation service only).
• Limitations: Navigation only — does not provide treatment directly; processing time varies.
• Cost: No charge for navigation support.

Veteran ketamine therapy: side-by-side comparison

Beyond ketamine: MDMA and psilocybin trials for veterans

Ketamine is the most immediately accessible option for veterans seeking psychedelic-adjacent treatment, but it is not the only one. MDMA-assisted therapy for PTSD was granted Breakthrough Therapy Designation by the FDA in 2017. While the FDA declined to approve LYKOS Therapeutics' MDMA application in 2024, clinical trials continue to enroll. Veterans made up a significant portion of the original MAPS PTSD trials.

Psilocybin trials for PTSD and moral injury are also enrolling in several academic institutions. Check ClinicalTrials.gov for veteran-specific psilocybin and MDMA trials. The Multidisciplinary Association for Psychedelic Studies (MAPS) maintains a patient access program for veterans in treatment- resistant cases. Our MDMA guide and psilocybin guide cover the current evidence and trial landscape in more detail.

Verdict: which ketamine therapy path is right for veterans?

Start with VETS or Warrior Angels if you are not sure where to begin. Both organizations provide free navigation, and VETS can fund treatment for eligible veterans — eliminating the cost barrier that stops many veterans from pursuing care.

If you have VA health care and treatment-resistant depression: ask your VA psychiatrist about Spravato. It is covered, FDA-approved, and available at VA facilities — the clearest zero-cost path for eligible veterans.

If you want supervised IV ketamine: Stella Center (PTSD + pain) or Revitalist (if in a coverage area) are the most veteran-aligned clinic options.

If cost and accessibility are the primary constraints: Mindbloom's veteran discount plus their at-home model is the lowest-friction entry point — while being aware that at-home ketamine has different bioavailability and supervision levels than IV infusion.

For more context on ketamine's evidence base, delivery models, and risks, read our complete ketamine therapy guide. To compare ketamine with other treatment options, use our depression treatment path tool.